Overview
BNR market data
Price History
BNR price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.45 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.31 – $41.72 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $94.1 · P/B 2.81 · P/S 1.24.
Company news
Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2KBenzinga · Jul 2, 2026, 11:30 AM
Why These High-Flying Stocks Came Back To EarthBenzinga · Jun 12, 2026, 12:30 PM
Earnings Scheduled For June 9, 2026Benzinga · Jun 9, 2026, 3:20 PM
Burning Rock Biotech Q1 EPS $(0.20), Same YoY, Sales $15.649M Down From $18.340M YoYBenzinga · Jun 9, 2026, 2:20 PM